Expertise in
2
conditions

Satoru Arai

St. Luke's International Hospital, 9-1 Akashi Cho, 
Chuo, JP 
Expertise in
2
conditions
St. Luke's International Hospital, 9-1 Akashi Cho, 
Chuo, JP 

Overview

Satoru Arai practices practicing medicine in Chuo, Japan.

Mr. Arai is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Generalized Pustular Psoriasis (GPP), Pustular Psoriasis, Splinter Hemorrhages, and Togaviridae Disease.

He is actively involved in clinical research, co-authoring 24 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

St. Luke's International Hospital, 9-1 Akashi Cho, Chuo, 1048560, Japan
Other Locations
St Luke's International University
Tokyo, Japan
St. Luke's International Hospital
Japan
Sagamihara, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

24 Total Publications

Clinical practice guideline for pediatric IgA vasculitis in Japan 2023: a digest-secondary publication.
Clinical practice guideline for pediatric IgA vasculitis in Japan 2023: a digest-secondary publication.
Journal: Clinical and experimental nephrology
Published: November 24, 2025

Frequently Asked Questions about Satoru Arai

Is Satoru Arai a top-rated expert for Generalized Pustular Psoriasis (GPP)?

MediFind is an objective health platform that identifies experts based on real-world data. Satoru Arai is classified as an Advanced expert for Generalized Pustular Psoriasis (GPP), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Satoru Arai participate in research or clinical trials?

Yes. Satoru Arai has published 24 articles and abstracts on conditions like Generalized Pustular Psoriasis (GPP). You can view a list of Satoru Arai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Arai's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile